Congress faces uphill battle to stop flow of fentanyl, deadliest drug on the streets


Full story

More than 100,000 Americans died of drug overdoses in the United States during a 12-month period ending in April 2021–more than car crashes and gunshot wounds combined–according to data from the CDC. The CDC calculated fentanyl was behind more than half of those deaths. 

“It’s truly the epidemic within the pandemic,” Sen. Rob Portman (R-OH) said. 

Members of Congress are working to address the issue. Sen. Portman and Sen. Joe Manchin (D-WV) both represent states heavily impacted by fentanyl. The two lawmakers reached across the aisle and introduced legislation to keep the deadly synthetic drug out of American communities.

In February 2018, the Drug Enforcement Administration (DEA) issued a temporary scheduling order to schedule fentanyl-related substances that has allowed federal law enforcement authorities to bring criminal actions against individuals who manufacture, distribute, or handle fentanyl-related substances,” according to a news release from Portman’s office. Their proposal, the Federal Initiative to Guarantee Health by Targeting (FIGHT) Fentanyl Act, would make that temporary order permanent.

SAN provides
Unbiased. Straight Facts.

Don’t just take our word for it.


Certified balanced reporting

According to media bias experts at AllSides

AllSides Certified Balanced May 2025

Transparent and credible

Awarded a perfect reliability rating from NewsGuard

100/100

Welcome back to trustworthy journalism.

Find out more

SAN provides
Unbiased. Straight Facts.

Don’t just take our word for it.


Certified balanced reporting

According to media bias experts at AllSides

AllSides Certified Balanced May 2025

Transparent and credible

Awarded a perfect reliability rating from NewsGuard

100/100

Welcome back to trustworthy journalism.

Find out more

Daily Newsletter

Start your day with fact-based news

Start your day with fact-based news

Learn more about our emails. Unsubscribe anytime.

By entering your email, you agree to the Terms and Conditions and acknowledge the Privacy Policy.